US Patent Issued to AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION on Oct. 21 for "Composition for diagnosing, preventing, or treating cognitive dysfunction comprising COTL1 as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,194, issued on Oct. 21, was assigned to AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Suwon-si, South Korea).

"Composition for diagnosing, preventing, or treating cognitive dysfunction comprising COTL1 as active ingredient" was invented by Seon Yong Jeong (Yongin-si, South Korea) and Eunkuk Park (Suwon-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition for diagnosing, preventing, or treating cognitive dysfunction comprising, as an active ingredient, COTL1 protein or a gene encoding same is described."

The patent was filed on Nov. 19, 2020, under Application No. 17/777,464.

*For further information, including i...